Premier Group hands nSpire Health three-year deal
This article was originally published in Clinica
Executive Summary
Longmont, Colorado-based respiratory care products manufacturer nSpire Health has signed a three-year deal to make its range of technology available through Premier Group Purchasing’s network of hospitals and clinics. The deal, which expires on July 1 2011, provides Premier’s clients with its range of products including the HDpft pulmonary function testing system and metabolic diagnostic instrumentation and the iFlow flow sensor technology. San Diego, California-based Premier will make the technology available to its group of more than 2,000 US hospitals and 50,000 healthcare sites. Financial details of the deal were not revealed.
You may also be interested in...
Alere aided by professional diagnostics sales in fourth quarter
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra and Stout to work on expandable interbody device
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe eyes portfolio expansion to help boost molecular diagnostics credentials
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals